Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Ixazomib is an oral proteasome inhibitor primarily used clinically to treat mult···【more】
Release date：2026-03-13Recommended：79
Ibrutinib is an oral Bruton's tyrosine kinase (BTK) inhibitor that was first···【more】
Release date：2026-03-12Recommended：59
Ibrutinib (Imbruvica) is an oral Bruton's tyrosine kinase (BTK) inhibitor us···【more】
Release date：2026-03-12Recommended：49
Ibrutinib is a small molecule that acts as a potent, irreversible inhibitor of B···【more】
Release date：2026-03-12Recommended：57
Ibrutinib (Imbruvica) is a type of medication called a kinase inhibitor, used to···【more】
Release date：2026-03-12Recommended：45
What are the common adverse reactions to Gilteritinib fumarate?Common reactions ···【more】
Release date：2026-03-11Recommended：71
What drugs does Gilteritinib Fumarate Tablets interact with?Before taking this m···【more】
Release date：2026-03-11Recommended：62
Use of Gilteritinib Fumarate Tablets with Other MedicationsDuring treatment, doc···【more】
Release date：2026-03-11Recommended：57
Indications and EfficacyThe main component of Gilteritinib Fumarate Tablets is g···【more】
Release date：2026-03-11Recommended：57
During treatment with Selumetinib, in addition to its expected therapeutic effec···【more】
Release date：2026-03-10Recommended：86
August 1, 2017 -- The U.S. Food and Drug Administration today approved Enasideni···【more】
Release date：2026-03-10Recommended：64
During treatment with Enasidenib, in addition to the expected therapeutic effect···【more】
Release date：2026-03-10Recommended：74
